Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes

被引：9
作者：
Burge, MR
Carey, JD
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Dept Med, Albuquerque, NM USA
[2] Albuquerque Dermatol Associates, Albuquerque, NM USA
来源：
DIABETES CARE | 2004年 / 27卷 / 01期
关键词：
D O I：
10.2337/diacare.27.1.275
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 276
页数：2
相关论文
共 6 条
[1]  
BIRLEA S, 2003, PIGM CELL RES, V16, P603
[2]   Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin [J].
Fineberg, NS ;
Fineberg, SE ;
Anderson, JH ;
Birkett, MA ;
Gibson, RG ;
Hufferd, S .
DIABETES, 1996, 45 (12) :1750-1754
[3]   Cutaneous allergy to human (recombinant DNA) insulin [J].
Gonzalo, MA ;
De Argila, D ;
Revenga, F ;
Garcia, JM ;
Diaz, J ;
Morales, F .
ALLERGY, 1998, 53 (01) :106-107
[4]   Autoimmune aspects of vitiligo [J].
Kemp, EH ;
Waterman, EA ;
Weetman, AP .
AUTOIMMUNITY, 2001, 34 (01) :65-77
[5]   Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes [J].
Lindholm, A ;
Jensen, LB ;
Home, PD ;
Raskin, P ;
Boehm, BO ;
Råstam, J .
DIABETES CARE, 2002, 25 (05) :876-882
[6]   Skin lesions in diabetes mellitus:: prevalence and clinical correlations [J].
Romano, G ;
Moretti, G ;
Di Benedetto, A ;
Giofrè, C ;
Di Cesare, E ;
Russo, G ;
Califano, L ;
Cucinotta, D .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 39 (02) :101-106
1